Layered with Coriell’s inventory management system, IBM software allows Coriell to electronically track each sample as it moves through various laboratory processes.

These samples vary greatly in type, disease state, age, and other characteristics, and the ability to quickly pinpoint the location and specific processing stage of a particular sample provides a key advantage to Coriell.

Coriell can increase its capacity to manage the volume of data generated by analyzing the genomes of large and diverse populations needed to examine the causes of critical diseases such as diabetes, cancer, and heart disease.

Coriell chief information officer Scott Megill said the breadth of data output created by their research introduced new challenges to analyze and store this information and IBM is enabling the company to effectively gather and analyze this data for our research.

The complete Coriell solution is powered by IBM technology that includes – IBM XIV Storage System, IBM Tivoli Maximo, IBM Tivoli Netcool and IBM WebSphere Lombardi Edition.